Condition: Pelvic Organ Prolapse (POP) · Genital Prolapse · Uterus Prolapse · Sponsor: A.M.I. Agency for Medical Innovations GmbH
The purpose of the clinical investigation is to verify that the investigational device (LatGYNious) is appropriate to significantly improve the pelvic organ prolapse in patients.
This description comes directly from the study's public registry record.
Florian Blab · +43 5522 90505 4062 · florian.blab@ami.at
Always discuss trial participation with your own doctor first.
| BZK St. Johann in Tirol | Sankt Johann in Tirol, Tyrol, Austria | Recruiting |
| Universitätsklinikum Wiener Neustadt, Klinische Abteilung für Gynäkologie und Geburtshilfe | Wiener Neustadt, Austria | Recruiting |
| Universitätsklinik Brandenburg a.d. Havel, Klinik für Frauenheilkunde und Geburtshilfe | Brandenburg, Germany | Not Yet Recruiting |
| Krankenhaus St. Joseph-Stift Bremen | Bremen, Germany | Not Yet Recruiting |
| Medizincampus Bodensee - Klinik Tettnang | Tettnang, Germany | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07066761